Skip to main content

Prescription medicine

Follitropin alfa Brand names: Gonal-F

Follitropin alfa (Gonal-F) is a prescription medicine. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the follitropin alfa FDA label on DailyMed (effective September 2, 2025); every follitropin alfa label on DailyMed.

Highlights of the record

FDA label of September 2, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

GONAL-f is indicated for: GONAL-f is a gonadotropin indicated for: Women: Induction of ovulation and pregnancy in oligo-anovulatory infertile women for whom the cause of infertility is functional and not due to primary ovarian failure.

Forms and strengths

Kit.

On the market

Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
2,009 through July 30, 2026

What is follitropin alfa used for?

From the label: indications and usage

GONAL-f is indicated for: GONAL-f is a gonadotropin indicated for: Women: Induction of ovulation and pregnancy in oligo-anovulatory infertile women for whom the cause of infertility is functional and not due to primary ovarian failure. ( 1.1 ) Development of multiple follicles in ovulatory infertile women as part of Assisted Reproductive Technology (ART) cycles. ( 1.2 ) Men: Induction of spermatogenesis in infertile men with primary and secondary hypogonadotropic hypogonadism for whom the cause of infertility is not due to primary testicular failure. […]

Source: FDA drug label (Gonal-f), EMD Serono, Inc., effective September 2, 2025 (SPL set ae85b9c3-e7eb-4981-a5d9-346050e8f189), via openFDA; the full label on DailyMed

Is there a generic for follitropin alfa (Gonal-F)?

No generic follitropin alfa is approved (Drugs@FDA, October 8, 2026).

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the follitropin alfa label say about other medicines?

The follitropin alfa label names 3 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Estradiolwarnings and precautionsThe combination of both ultrasound and serum estradiol measurement are useful for monitoring follicular growth and maturation, timing of the ovulatory trigger, detecting ovarian enlargement and minimizing the risk of the OHSS and multiple gestation.
FollitropincontraindicationsCONTRAINDICATIONS GONAL-f is contraindicated in women and men who exhibit: Prior hypersensitivity to recombinant FSH products or one of their excipients.
Progesteronewarnings and precautionsDirect or indirect indices of progesterone production: Urinary or serum luteinizing hormone (LH) rise A rise in basal body temperature Increase in serum progesterone Menstruation following a shift in basal body temperature Sonographic evidence of ovulation:

Check follitropin alfa against other medicines

Source: FDA drug label (Gonal-f), EMD Serono, Inc., effective September 2, 2025 (SPL set ae85b9c3-e7eb-4981-a5d9-346050e8f189), via openFDA; the full label on DailyMed

What do FAERS reports show for follitropin alfa?

The FDA Adverse Event Reporting System holds 2,009 reports that list follitropin alfa among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 30 are coded as a death and 973 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

Reports received each year

The most reported reactions

  • Ovarian Hyperstimulation Syndrome (named in the label)687
  • Ascites223
  • Abdominal Pain (named in the label)128
  • Abortion Spontaneous123
  • Abdominal Distension (named in the label)116
  • Nausea (named in the label)101
  • Dyspnoea (named in the label)100
  • Vomiting (named in the label)83

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Follitropin alfa side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other